News Apixaban Bests Rivaroxaban in “Emulated” Trial of Patients With Afib and VHD Publish Date October 19, 2022 Apixaban and rivaroxaban are both factor Xa inhibitors.
Drugs in the Pipeline Novel Factor XI Inhibitor Fast Tracked for Thrombosis Associated With Cancer Publish Date July 11, 2022 Abelacimab is a highly selective, fully human monoclonal antibody designed to inhibit both factor XI and its activated form, factor XIa.